IL284712A - וקטורים מולקולריים מובנים ושימושים שלהם - Google Patents

וקטורים מולקולריים מובנים ושימושים שלהם

Info

Publication number
IL284712A
IL284712A IL284712A IL28471221A IL284712A IL 284712 A IL284712 A IL 284712A IL 284712 A IL284712 A IL 284712A IL 28471221 A IL28471221 A IL 28471221A IL 284712 A IL284712 A IL 284712A
Authority
IL
Israel
Prior art keywords
inflammatory compounds
structured molecular
molecular vectors
vectors
structured
Prior art date
Application number
IL284712A
Other languages
English (en)
Original Assignee
Univ Claude Bernard Lyon
Centre Nat Rech Scient
Inst Nat Sante Rech Med
Univ Jean Monnet Saint Etienne
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Claude Bernard Lyon, Centre Nat Rech Scient, Inst Nat Sante Rech Med, Univ Jean Monnet Saint Etienne filed Critical Univ Claude Bernard Lyon
Publication of IL284712A publication Critical patent/IL284712A/he

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/131Amines acyclic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40Esters thereof
    • C07F9/4003Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006Esters of acyclic acids which can have further substituents on alkyl
    • C07F9/4009Esters containing the structure (RX)2P(=X)-alk-N...P (X = O, S, Se)
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/03Organic compounds
    • A23L29/035Organic compounds containing oxygen as heteroatom
    • A23L29/04Fatty acids or derivatives
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12Fatty acids or derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/661Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/662Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/683Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/683Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/688Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols both hydroxy compounds having nitrogen atoms, e.g. sphingomyelins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3808Acyclic saturated acids which can have further substituents on alkyl
    • C07F9/3817Acids containing the structure (RX)2P(=X)-alk-N...P (X = O, S, Se)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Rheumatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Mycology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Ophthalmology & Optometry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IL284712A 2019-02-21 2021-07-08 וקטורים מולקולריים מובנים ושימושים שלהם IL284712A (he)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP19305212 2019-02-21
EP19306376 2019-10-23
PCT/EP2020/054662 WO2020169822A1 (en) 2019-02-21 2020-02-21 Structured molecular vectors for anti-inflammatory compounds and uses thereof

Publications (1)

Publication Number Publication Date
IL284712A true IL284712A (he) 2021-08-31

Family

ID=69593711

Family Applications (1)

Application Number Title Priority Date Filing Date
IL284712A IL284712A (he) 2019-02-21 2021-07-08 וקטורים מולקולריים מובנים ושימושים שלהם

Country Status (12)

Country Link
US (1) US20220162239A1 (he)
EP (1) EP3927348A1 (he)
JP (1) JP2022521414A (he)
KR (2) KR20220082117A (he)
CN (1) CN113677349B (he)
AU (1) AU2020225354A1 (he)
BR (1) BR112021015307A2 (he)
CA (1) CA3126203A1 (he)
IL (1) IL284712A (he)
MX (1) MX2021009328A (he)
SG (1) SG11202107578QA (he)
WO (1) WO2020169822A1 (he)

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3435156A1 (de) * 1984-09-25 1986-04-03 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren zur herstellung der stereoisomeren von 1-amino-alkylphosphonsaeuren oder 1-aminoalkylphosphinsaeuren
HU203360B (en) * 1988-11-25 1991-07-29 Monsanto Co Process for producing n-acylamino methylphosphonates
US6150345A (en) 1998-08-10 2000-11-21 Regents Of The University Of California Methods for promoting survival of myelin producing cells
SE9900941D0 (sv) * 1998-12-23 1999-03-16 Nomet Management Serv Bv Novel retinoic acid derivatives and their use
US6838452B2 (en) * 2000-11-24 2005-01-04 Vascular Biogenics Ltd. Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis
EP1469083A1 (en) 2003-04-17 2004-10-20 Centre National De La Recherche Scientifique (Cnrs) Method of calibration of reverse transcription using a synthetic messenger RNA (smRNA) as an internal control
US20050130937A1 (en) 2003-10-22 2005-06-16 Enzymotec Ltd. Lipids containing omega-3 and omega-6 fatty acids
EP1931664A4 (en) * 2005-09-15 2010-12-08 Painceptor Pharma Corp PROCESS FOR MODULATING NEUROTROPHINE-MEDIATED ACTIVITY
WO2011113507A2 (en) * 2010-03-15 2011-09-22 Ulrich Dietz Use of nitrocarboxylic acids for the treatment, diagnosis and prophylaxis of aggressive healing patterns
JP6139781B2 (ja) * 2014-04-04 2017-05-31 国立大学法人大阪大学 リゾリン脂質受容体を活性化する物質を含有する薬剤送達促進剤
JP7041673B2 (ja) * 2016-10-13 2022-03-24 カーノット, エルエルシー N-アシルエタノールアミド誘導体およびその使用
FR3063645B1 (fr) 2017-03-08 2021-06-11 Lipther Acefapc pour le traitement des maladies acetylcholine dependantes
US20180303821A1 (en) * 2017-04-24 2018-10-25 BraneQuest, Inc. Membrane active molecules

Also Published As

Publication number Publication date
AU2020225354A8 (en) 2021-09-02
SG11202107578QA (en) 2021-08-30
EP3927348A1 (en) 2021-12-29
CN113677349A (zh) 2021-11-19
WO2020169822A1 (en) 2020-08-27
MX2021009328A (es) 2021-11-12
KR20210042385A (ko) 2021-04-19
BR112021015307A2 (pt) 2021-11-09
CA3126203A1 (en) 2020-08-27
JP2022521414A (ja) 2022-04-07
KR102411189B1 (ko) 2022-06-23
US20220162239A1 (en) 2022-05-26
KR20220082117A (ko) 2022-06-16
CN113677349B (zh) 2024-03-19
AU2020225354A1 (en) 2021-08-12

Similar Documents

Publication Publication Date Title
EP3583507A4 (en) BLOCKCHAIN-BASED ADMISSION PROCESS FOR PROTECTED ENTITIES
IL285178A (he) תירכובות והשימוש בהם
GB201905265D0 (en) Inflammasome inhibition
IL285177A (he) תירכובות והשימוש בהם
EP3762391A4 (en) SPIROCENTRIC COMPOUNDS AND POLYMERS THEREOF
IL286497A (he) תירכובות והשימוש בהן
IL278142A (he) תרכובות נגד שגשוג ושימושים בהן
IL291499A (he) תרכובות אזאקינולין ושימושים שלהם
EP3962431A4 (en) LEAVE-IN SHAMPOO COMPOSITION
IL288412A (he) פפטידים
IL291260A (he) תכשיר אנתרנילאמיד
IL285118A (he) תרכובות ושימושים שלהן
IL284764A (he) תרכובות ושימושים בהן
AU2018301804A1 (en) Molecular guide system peptides and uses thereof
IL282999A (he) תרכובת 4,3,1-אוקסאדיאזולון ותרופה
EP3448309A4 (en) TREATMENT OF SYSTEMIC SCLEROSIS WITH IFETROBAN
IL284712A (he) וקטורים מולקולריים מובנים ושימושים שלהם
EP3416975A4 (en) NEW ALPHA-CONOTOXIN PEPTIDES
EP3818070A4 (en) SYNTHETIC PEPTIDES, PRODRUGS, PHARMACEUTICAL COMPOSITIONS AND USES
EP3898652A4 (en) MITOCHONDRIAL TARGETING PEPTIDES
EP3841108A4 (en) PHARMACEUTICAL COMPOSITIONS COMPRISING INTEGRATION-PROMOTING PEPTIDES
ZA202201239B (en) Aminothiolester compounds and uses thereof
IL282062A (he) ויניגרט
GB201913236D0 (en) Flange clamps
EP3919259A4 (en) HEAT-SHRINKABLE TUBING WITH TEAR PROPERTIES